PubChemID,Chemical name,SMILE,Class,Rank,class.
187,acetylcholine chloride,CC(=O)OCC[N+](C)(C)C,negative,non-DILI,0
12035,acetylcysteine,CC(=O)N[C@@H](CS)C(=O)O,negative,non-DILI,0
60961,adenosine,C1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,negative,non-DILI,0
51263,alfentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,negative,non-DILI,0
123606,almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,negative,non-DILI,0
5488548,alvimopan,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O,negative,non-DILI,0
2131,ambenonium,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl,negative,non-DILI,0
2141,amifostine,C(CN)CNCCSP(=O)(O)O,negative,non-DILI,0
37768,amikacin,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,negative,non-DILI,0
564,aminocaproic acid,C(CCC(=O)O)CCN,negative,non-DILI,0
2148,aminohippurate,C1=CC(=CC=C1C(=O)NCC(=O)O)N,negative,non-DILI,0
6005,apomorphine,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(=C(C=C4)O)O,negative,non-DILI,0
152951,argatroban,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@@H](C3)C,negative,non-DILI,0
47319,atracurium,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C,negative,non-DILI,0
174174,atropine,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,negative,non-DILI,0
65628,bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,negative,non-DILI,0
2341,benzphetamine,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2,negative,non-DILI,0
247,betaine,C[N+](C)(C)CC(=O)[O-],negative,non-DILI,0
2370,bethanechol,CC(C[N+](C)(C)C)OC(=O)N,negative,non-DILI,0
2381,biperiden,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O,negative,non-DILI,0
16129704,bivalirudin,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]5CCCN5C(=O)[C@@H](CC6=CC=CC=C6)N,negative,non-DILI,0
6834,brompheniramine,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2,negative,non-DILI,0
63006,budesonide,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,negative,non-DILI,0
5361092,butorphanol,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,negative,non-DILI,0
2519,caffeine,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,negative,non-DILI,0
134070,calcitriol,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,negative,non-DILI,0
2564,carbinoxamine,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,negative,non-DILI,0
2576,carisoprodol,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,negative,non-DILI,0
298,chloramphenicol,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],negative,non-DILI,0
2725,chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,negative,non-DILI,0
156419,cinacalcet,C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,negative,non-DILI,0
26987,clemastine,C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C,negative,non-DILI,0
153994,clevidipine,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,negative,non-DILI,0
216258,colistimethate,CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC(C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+],negative,non-DILI,0
151171,conivaptan,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,negative,non-DILI,0
16132344,corticorelin ovine triflutate,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N,negative,non-DILI,0
16132357,corticotropin,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N,negative,non-DILI,0
16129617,cosyntropin,CC(C)[C@@H](C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC8=CNC=N8)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C(CO)N,negative,non-DILI,0
5462245,cyanocobalamin,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3C(C([C@@H](O3)CO)OP(=O)(O)OC(C)CNC(=O)CC[C@@]\4([C@H](C5[C@]6([C@@]([C@@H](C(=N6)/C(=C\7/[C@@]([C@@H](C(=N7)/C=C\8/C([C@@H](C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],negative,non-DILI,0
444031,darifenacin,C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,negative,non-DILI,0
5826,dextroamphetamine,C[C@@H](CC1=CC=CC=C1)N,negative,non-DILI,0
5360696,dextromethorphan,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,negative,non-DILI,0
2140,diatrizoate,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,negative,non-DILI,0
3042,dicyclomine,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,negative,non-DILI,0
7029,diethylpropion,CCN(CC)C(C)C(=O)C1=CC=CC=C1,negative,non-DILI,0
30322,digoxin,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,negative,non-DILI,0
10531,dihydroergotamine,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C,negative,non-DILI,0
3080,dimercaprol,C(C(CS)S)O,negative,non-DILI,0
3100,diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,negative,non-DILI,0
36811,dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,negative,non-DILI,0
71329,dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,negative,non-DILI,0
681,dopamine,C1=CC(=C(C=C1CCN)O)O,negative,non-DILI,0
3156,doxapram,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,negative,non-DILI,0
3162,doxylamine,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C,negative,non-DILI,0
3168,droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,negative,non-DILI,0
152945,dutasteride,C[C@]12CCC3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,negative,non-DILI,0
3182,dyphylline,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,negative,non-DILI,0
44152182,ecallantide,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4CCC[C@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N5CCC[C@H]5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)[C@H](C)O)CC1=CC=CC=C1)[C@@H](C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,negative,non-DILI,0
3202,edrophonium,CC[N+](C)(C)C1=CC(=CC=C1)O,negative,non-DILI,0
5816,epinephrine,CNC[C@@H](C1=CC(=C(C=C1)O)O)O,negative,non-DILI,0
123610,eptifibatide,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,negative,non-DILI,0
59768,esmolol,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,negative,non-DILI,0
3261,estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,negative,non-DILI,0
3305,etidronic acid,CC(O)(P(=O)(O)O)P(=O)(O)O,negative,non-DILI,0
36339,etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,negative,non-DILI,0
16157882,exenatide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC8=CC=CC=C8)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC9=CN=CN9)N,negative,non-DILI,0
3341,fenoldopam,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,negative,non-DILI,0
9849808,fesoterodine,CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=C/C(=O)O)\C(=O)O,negative,non-DILI,0
3354,flavoxate,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,negative,non-DILI,0
31378,fludrocortisone,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O)F,negative,non-DILI,0
3373,flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,negative,non-DILI,0
16850,fluorescein,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,negative,non-DILI,0
6037,folic acid,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,negative,non-DILI,0
77992,frovatriptan,CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,negative,non-DILI,0
60714,gadoteridol,CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3],negative,non-DILI,0
444013,gadoversetamide,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],negative,non-DILI,0
16130957,ganirelix acetate,CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC,negative,non-DILI,0
3494,glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,negative,non-DILI,0
3516,guaifenesin,COC1=CC=CC=C1OCC(CO)O,negative,non-DILI,0
3518,guanethidine,C1CCCN(CCC1)CCN=C(N)N,negative,non-DILI,0
3658,hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,negative,non-DILI,0
60852,ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,negative,non-DILI,0
60753,ibutilide,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,negative,non-DILI,0
19190,indocyanine green,CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+],negative,non-DILI,0
3739,iodipamide meglumine,C1=C(C(=C(C(=C1I)NC(=O)CCCCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I,negative,non-DILI,0
3741,ioversol,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO,negative,non-DILI,0
3779,isoproterenol,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,negative,non-DILI,0
6883,isosorbide dinitrate,C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O[N+](=O)[O-])O[N+](=O)[O-],negative,non-DILI,0
6032,kanamycin,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,negative,non-DILI,0
10917,l-carnitine,C[N+](C)(C)C[C@@H](CC(=O)[O-])O,negative,non-DILI,0
54575,leucovorin,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@H](CCC(=O)O)C(=O)O,negative,non-DILI,0
143,Levoleucovorin,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,negative,non-DILI,0
13109,levonorgestrel,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,negative,non-DILI,0
5359272,levorphanol,CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O,negative,non-DILI,0
3676,lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,negative,non-DILI,0
5920,liothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,negative,non-DILI,0
3955,loperamide,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,negative,non-DILI,0
656719,lubiprostone,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@H]2CCCCCCC(=O)O)O)(F)F,negative,non-DILI,0
453,mannitol,C(C(C(C(C(CO)O)O)O)O)O,negative,non-DILI,0
4032,mecamylamine,CC1(C2CCC(C2)C1(C)NC)C,negative,non-DILI,0
4034,meclizine,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,negative,non-DILI,0
4057,mepenzolate,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C,negative,non-DILI,0
4058,meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,negative,non-DILI,0
4062,mepivacaine,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C,negative,non-DILI,0
4064,meprobamate,CCCC(C)(COC(=O)N)COC(=O)N,negative,non-DILI,0
10836,methamphetamine,C[C@@H](CC1=CC=CC=C1)NC,negative,non-DILI,0
6476,methsuximide,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2,negative,non-DILI,0
8226,methylergonovine,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,negative,non-DILI,0
9681,methysergide,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,negative,non-DILI,0
4174,metyrapone,CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2,negative,non-DILI,0
441350,metyrosine,C[C@](CC1=CC=C(C=C1)O)(C(=O)O)N,negative,non-DILI,0
4192,midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,negative,non-DILI,0
4195,midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,negative,non-DILI,0
55245,mifepristone,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,negative,non-DILI,0
441314,miglitol,C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O,negative,non-DILI,0
51634,miglustat,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O,negative,non-DILI,0
4201,minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,negative,non-DILI,0
4211,mitotane,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,negative,non-DILI,0
5281042,mivacurium,C[N+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C,negative,non-DILI,0
5288826,morphine,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,negative,non-DILI,0
5284592,nabilone,CCCCCCC(C)(C)C1=CC2=C([C@@H]3CC(=O)CC[C@H]3C(O2)(C)C)C(=C1)O,negative,non-DILI,0
5360630,nalbuphine,C1CC(C1)CN2CC[C@]34C5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O,negative,non-DILI,0
5284596,naloxone,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,negative,non-DILI,0
4454,neomycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,negative,non-DILI,0
25081014,nesiritide,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CO)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC4C=NC=N4)C(=O)O)CC(C)C)CO)CO)CO)CO,negative,non-DILI,0
41684,nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],negative,non-DILI,0
4510,nitroglycerin,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],negative,non-DILI,0
439260,norepinephrine,C1=CC(=C(C=C1[C@H](CN)O)O)O,negative,non-DILI,0
11953884,nystatin,C[C@@H]1[C@H]([C@@H]([C@@H](C(O1)OC\2CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C(C(/C=C/C=C/CC/C=C/C=C/C=C/C=C2)C)O)C)C)O)O)O)O)O)O)C(=O)O)O)O)N)O,negative,non-DILI,0
4086,orciprenaline,CC(C)NCC(C1=CC(=CC(=C1)O)O)O,negative,non-DILI,0
4601,orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,negative,non-DILI,0
4634,oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,negative,non-DILI,0
5284603,oxycodone,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,negative,non-DILI,0
5284604,oxymorphone,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,negative,non-DILI,0
439302,oxytocin,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,negative,non-DILI,0
115237,paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,negative,non-DILI,0
27350,pancuronium,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],negative,non-DILI,0
165580,paromomycin,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N,negative,non-DILI,0
37464,penbutolol,CC(C)(C)NC[C@@H](COC1=CC=CC=C1C2CCCC2)O,negative,non-DILI,0
6869,penicillin v,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,negative,non-DILI,0
444007,pentagastrin,CC(C)COC(=O)NCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N,negative,non-DILI,0
441278,pentazocine,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O,negative,non-DILI,0
12460,phendimetrazine,CC1C(OCCN1C)C2=CC=CC=C2,negative,non-DILI,0
4768,phenoxybenzamine,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,negative,non-DILI,0
5775,phentolamine,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,negative,non-DILI,0
4812,phytonadione,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,negative,non-DILI,0
4828,pindolol,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,negative,non-DILI,0
65015,plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,negative,non-DILI,0
16132446,pramlintide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CN=CN6)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)N,negative,non-DILI,0
4908,primaquine,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,negative,non-DILI,0
4909,primidone,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,negative,non-DILI,0
4919,procyclidine,C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O,negative,non-DILI,0
4934,propantheline,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C,negative,non-DILI,0
638678,protirelin,C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CCC(=O)N3)C(=O)N,negative,non-DILI,0
4976,protriptyline,CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13,negative,non-DILI,0
7028,pseudoephedrine,C[C@@H]([C@H](C1=CC=CC=C1)O)NC,negative,non-DILI,0
4991,pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,negative,non-DILI,0
1054,pyridoxine,CC1=NC=C(C(=C1O)CO)CO,negative,non-DILI,0
4999,quazepam,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,negative,non-DILI,0
5035,raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,negative,non-DILI,0
208902,ramelteon,CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3,negative,non-DILI,0
56959,ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,negative,non-DILI,0
219024,regadenoson,CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,negative,non-DILI,0
5770,reserpine,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,negative,non-DILI,0
5071,rimantadine,CC(C12CC3CC(C1)CC(C3)C2)N,negative,non-DILI,0
5078,rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,negative,non-DILI,0
441290,rocuronium,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,negative,non-DILI,0
2083,salbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,negative,non-DILI,0
16129665,secretin,CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC2=NC=CN2)N,negative,non-DILI,0
26757,selegiline,C[C@H](CC1=CC=CC=C1)N(C)CC#C,negative,non-DILI,0
9833444,sincalide,CSCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)O)N,negative,non-DILI,0
82170,sorbitol,C([C@H]([C@@H]([C@H]([C@H](CO)O)O)O)O)O,negative,non-DILI,0
19649,streptomycin,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,negative,non-DILI,0
6398588,sucralfate,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-].O.O.O.[Al],negative,non-DILI,0
41693,sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,negative,non-DILI,0
6433091,tapentadol,CCC(C1=CC(=CC=C1)O)C(C)CN(C)C,negative,non-DILI,0
6918289,temsirolimus,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC,negative,non-DILI,0
5401,terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,negative,non-DILI,0
16133850,teriparatide,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N,negative,non-DILI,0
2153,theophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2,negative,non-DILI,0
1130,thiamine,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO,negative,non-DILI,0
60937,tiludronate,C1=CC(=CC=C1SC(P(=O)(O)O)P(=O)(O)O)Cl,negative,non-DILI,0
60947,tirofiban,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,negative,non-DILI,0
60774,tolterodine,CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,negative,non-DILI,0
60700,topotecan,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O,negative,non-DILI,0
5526,tranexamic acid,C1CC(CCC1CN)C(=O)O,negative,non-DILI,0
5572,trihexyphenidyl,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,negative,non-DILI,0
5282443,triprolidine,CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC=N3,negative,non-DILI,0
3034812,trospium,C1CC[N+]2(C1)[C@H]3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],negative,non-DILI,0
62819,urofollitropin,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)C(C)O,negative,non-DILI,0
39764,vecuronium,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],negative,non-DILI,0
13342,vinblastine,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,negative,non-DILI,0
5311,vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,negative,non-DILI,0
5719,zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,negative,non-DILI,0
34869,amineptine,C1CC2=CC=CC=C2C(C3=CC=CC=C31)[NH2+]CCCCCCC(=O)O.[Cl-],positive,most-DILI,1
2717,chlormezanone,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,positive,most-DILI,1
65869,ebrotidine,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,positive,most-DILI,1
4495,nimesulide,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,positive,most-DILI,1
5591,troglitazone,CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O,positive,most-DILI,1
62959,trovafloxacin,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,positive,most-DILI,1
54897,alpidem,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,positive,most-DILI,1
39941,benoxaprofen,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O,positive,most-DILI,1
255968,benzarone,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC=C(C=C3)O,positive,most-DILI,1
2333,benzbromarone,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,positive,most-DILI,1
60726,bromfenac,C1=CC(=C(C(=C1)CC(=O)O)N)C(=O)C2=CC=C(C=C2)Br,positive,most-DILI,1
33176,clometacin,CC1=C(C2=C(N1CC(=O)O)C=C(C=C2)OC)C(=O)C3=CC=C(C=C3)Cl,positive,most-DILI,1
2898,cyclofenil,CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C,positive,most-DILI,1
15250,ibufenac,CC(C)CC1=CC=C(C=C1)CC(=O)O,positive,most-DILI,1
151166,lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,positive,most-DILI,1
4260,moxisylyte,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C,positive,most-DILI,1
8269,oxyphenisatin,CC(=O)OC1=CC=C(C=C1)C2(C3=CC=CC=C3NC2=O)C4=CC=C(C=C4)OC(=O)C,positive,most-DILI,1
4723,pemoline,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,positive,most-DILI,1
4746,perhexiline,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,positive,most-DILI,1
35935,pirprofen,CC(C1=CC(=C(C=C1)N2CC=CC2)Cl)C(=O)O,positive,most-DILI,1
38409,ticrynafen,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl,positive,most-DILI,1
53359,tolrestat,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,positive,most-DILI,1
9574101,ximelagatran,CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)/C(=N/O)/N,positive,most-DILI,1
50313,fialuridine,C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F)I,positive,most-DILI,1
60919,tasosartan,CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,positive,most-DILI,1
6437841,acitretin,CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C)C)C)OC,positive,most-DILI,1
2157,amiodarone,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,positive,most-DILI,1
104865,bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,positive,most-DILI,1
6253,cytarabine,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,positive,most-DILI,1
5351166,dacarbazine,CN(C)N/N=C\1/C(=NC=N1)C(=O)N,positive,most-DILI,1
28417,danazol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5,positive,most-DILI,1
2952,dantrolene,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],positive,most-DILI,1
5493381,deferasirox,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,positive,most-DILI,1
3331,felbamate,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,positive,most-DILI,1
3397,flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,positive,most-DILI,1
3767,isoniazid,C1=CN=CC=C1C(=O)NN,positive,most-DILI,1
47576,ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,positive,most-DILI,1
208908,lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,positive,most-DILI,1
3899,leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,positive,most-DILI,1
126941,methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,positive,most-DILI,1
4178,mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,positive,most-DILI,1
4449,nefazodone,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,positive,most-DILI,1
4463,nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,positive,most-DILI,1
5878,oxandrolone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C,positive,most-DILI,1
9902,oxymetholone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC(=CO)C(=O)C4)C,positive,most-DILI,1
10113978,pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,positive,most-DILI,1
40926,pentostatin,C1[C@H](C2=C(NC=N1)N(C=N2)C3CC(C(O3)CO)O)O,positive,most-DILI,1
18283,stavudine,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO,positive,most-DILI,1
5329102,sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,positive,most-DILI,1
4659569,tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],positive,most-DILI,1
3121,valproic acid,CCCC(CCC)C(=O)O,positive,most-DILI,1
35370,zidovudine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],positive,most-DILI,1
3002977,maraviroc,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,positive,most-DILI,1
4649,4-aminosalicylic acid,C1=CC(=C(C=C1N)O)C(=O)O,positive,most-DILI,1
65140,abacavir,C1CC1NC2=NC(=NC3=C2N=CN3C4C[C@H](C=C4)CO)N,positive,most-DILI,1
441184,acarbose,C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@@H]([C@@H]([C@H]4O)O)O)CO,positive,most-DILI,1
1983,acetaminophen,CC(=O)NC1=CC=C(C=C1)O,positive,most-DILI,1
1986,acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,positive,most-DILI,1
2082,albendazole,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,positive,most-DILI,1
2094,allopurinol,C1=C2C(=NC=NC2=O)NN1,positive,most-DILI,1
54841,atomoxetine,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,positive,most-DILI,1
60823,atorvastatin,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,positive,most-DILI,1
2265,azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],positive,most-DILI,1
82146,bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,positive,most-DILI,1
56069,bicalutamide,C[C@](CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,positive,most-DILI,1
93860,bortezomib,B([C@@H](CC(C)C)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,positive,most-DILI,1
2478,busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,positive,most-DILI,1
2554,carbamazepine,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,positive,most-DILI,1
2733,chlorzoxazone,C1=CC2=C(C=C1Cl)NC(=O)O2,positive,most-DILI,1
2764,ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,positive,most-DILI,1
84029,clarithromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,positive,most-DILI,1
2801,clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,positive,most-DILI,1
2818,clozapine,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,positive,most-DILI,1
6435893,cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,positive,most-DILI,1
2019,dactinomycin,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,positive,most-DILI,1
3033,diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,positive,most-DILI,1
50599,didanosine,C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O,positive,most-DILI,1
3059,diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,positive,most-DILI,1
39186,diltiazem,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,positive,most-DILI,1
60835,duloxetine,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,positive,most-DILI,1
176870,erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,positive,most-DILI,1
12560,erythromycin,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,positive,most-DILI,1
18140,estramustine,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl,positive,most-DILI,1
3308,etodolac,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,positive,most-DILI,1
193962,etravirine,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,positive,most-DILI,1
60198,exemestane,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,positive,most-DILI,1
3342,fenoprofen,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O,positive,most-DILI,1
3365,fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,positive,most-DILI,1
56339,fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,positive,most-DILI,1
123631,gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,positive,most-DILI,1
60750,gemcitabine,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,positive,most-DILI,1
3463,gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,positive,most-DILI,1
441140,griseofulvin,C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,positive,most-DILI,1
5291,imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,positive,most-DILI,1
3715,indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,positive,most-DILI,1
5282379,isotretinoin,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C,positive,most-DILI,1
55283,itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5CO[C@](O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,positive,most-DILI,1
3869,labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,positive,most-DILI,1
149096,levofloxacin,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,positive,most-DILI,1
4044,mefenamic acid,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,positive,most-DILI,1
667490,mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,positive,most-DILI,1
38853,methyldopa,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N,positive,most-DILI,1
3081921,micafungin,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,positive,most-DILI,1
5281021,minocycline,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)/C(=C(/N)\O)/C1=O)O)O)O)N(C)C,positive,most-DILI,1
9904,nandrolone decanoate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34,positive,most-DILI,1
938,niacin,C1=CC(=CN=C1)C(=O)O,positive,most-DILI,1
4493,nilutamide,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,positive,most-DILI,1
5353830,nitrofurantoin,C1C(=O)NC(=O)N1/N=C\C2=CC=C(O2)[N+](=O)[O-],positive,most-DILI,1
4543,nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,positive,most-DILI,1
3034010,orlistat,CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,positive,most-DILI,1
4680,papaverine,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,positive,most-DILI,1
1775,phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,positive,most-DILI,1
5381226,rifampin,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,positive,most-DILI,1
5070,riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,positive,most-DILI,1
392622,ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,positive,most-DILI,1
216239,sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,positive,most-DILI,1
5353980,sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C/3\C=CC(=O)C(=C3)C(=O)O,positive,most-DILI,1
5352,sulindac,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,positive,most-DILI,1
2733526,tamoxifen,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,positive,most-DILI,1
5462516,telithromycin,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,positive,most-DILI,1
5402,terbinafine,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,positive,most-DILI,1
6013,testosterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,positive,most-DILI,1
5430,thiabendazole,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,positive,most-DILI,1
5472,ticlopidine,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,positive,most-DILI,1
5487,tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,positive,most-DILI,1
71616,voriconazole,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,positive,most-DILI,1
5717,zafirlukast,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,positive,most-DILI,1
60490,zileuton,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,positive,most-DILI,1
